AccurEdit Therapeutics
PrivateLast Round
Series A
Sep 1, 2025
Est. Valuation
$147M
Total Funding Raised
$116M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
AccurEdit Therapeutics is a biotechnology company that develops in vivo gene editing therapies and delivery technologies for the treatment of severe or life-threatening genetic and acquired diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AccurEdit Therapeutics Comparables
Compare AccurEdit Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shape Therapeutics | 84% | |
| AIRNA | 81% | |
| Frequency Therapeutics | 79% |
AccurEdit Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 1, 2025 | ||||
| Seed | Sep 1, 2021 |
AccurEdit Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cormorant Asset Management | Seed |
| Legend Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 448% MoM, reaching 3.3K.
- Jul 13, 2026
Open roles increased to 71, 592% of headcount.
AccurEdit Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AccurEdit Therapeutics's valuation, stock price, and market status.
Is AccurEdit Therapeutics a public or private company?
AccurEdit Therapeutics is a private company.
What is the current stock price of AccurEdit Therapeutics?
AccurEdit Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is AccurEdit Therapeutics worth (valuation)?
Valuation information for AccurEdit Therapeutics is not publicly available.
Can I buy AccurEdit Therapeutics stock?
AccurEdit Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AccurEdit Therapeutics's last funding round?
Funding round information for AccurEdit Therapeutics is not publicly available.
Who are the main investors in AccurEdit Therapeutics?
Investor information for AccurEdit Therapeutics is not publicly disclosed.
Will AccurEdit Therapeutics IPO soon?
No public IPO plans have been announced for AccurEdit Therapeutics.
How can I track AccurEdit Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AccurEdit Therapeutics's secondary market activity and sign up for updates.